Valuation: Teva Pharmaceutical Industries Limited

Market Cap 38.67B 33.91B 31.25B 29.26B 54.87B 3,648B 56.01B 376B 145B 1,803B 145B 142B 6,252B P/E 2026 *
40.1x
P/E 2027 * 18x
Enterprise Value 49.86B 43.71B 40.29B 37.72B 70.74B 4,703B 72.21B 484B 187B 2,324B 187B 183B 8,060B EV / Sales 2026 *
3x
EV / Sales 2027 * 2.73x
Free-Float
88.61%
Yield 2026 *
-
Yield 2027 * -
1 day-1.22%
1 week+5.50%
Current month-5.97%
1 month-4.05%
3 months+11.52%
6 months+4.14%
Current year+6.41%
1 week 31.28
Extreme 31.28
34.69
1 month 30.8
Extreme 30.8
35.47
Current year 27.93
Extreme 27.93
37.34
1 year 14.99
Extreme 14.99
37.34
3 years 7.42
Extreme 7.42
37.34
5 years 6.78
Extreme 6.7791
37.34
10 years 6.07
Extreme 6.07
56.44
Manager TitleAgeSince
Chief Executive Officer 57 2022-12-31
Director of Finance/CFO 53 2019-12-21
Chief Operating Officer 52 2024-06-02
Director TitleAgeSince
Director/Board Member 69 2008-12-31
Chairman 78 2017-02-05
Director/Board Member 65 2015-08-31
Date Insider Type Main position Quantity % Market Cap.
06-17Sell

Chief Operating Officer

-9,989 0.0009%
06-10Sell

Chief Financial Officer

-106,563 0.0091%
06-04Fiscal year

Director

28,984 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%+5.50%+100.54%+334.69% 38.67B
+7.13%+9.97%+51.94%+166.83% 1,077B
+3.99%+11.50%+67.53%+55.63% 613B
+4.20%+17.03%+35.63%+87.74% 448B
+0.99%+4.85%+27.93%+22.82% 332B
+1.82%+8.19%+41.15%+26.80% 293B
+0.22%+6.75%+31.51%+42.02% 286B
+0.73%+8.53%-26.22%-40.85% 215B
+1.56%+6.14%+28.38%+59.45% 193B
+3.26%+3.33%+18.83%+67.03% 159B
Average +1.74%+7.75%+37.72%+82.22% 365.47B
Weighted average by Cap. +2.22%+8.89%+41.15%+83.96%

Financials

2026 *2027 *
Net sales 16.64B 14.59B 13.45B 12.59B 23.61B 1,570B 24.1B 162B 62.55B 776B 62.48B 61.12B 2,690B 17.24B 15.12B 13.93B 13.05B 24.46B 1,626B 24.97B 167B 64.8B 804B 64.74B 63.33B 2,787B
Net income 1.54B 1.35B 1.25B 1.17B 2.19B 146B 2.23B 14.99B 5.8B 71.92B 5.79B 5.67B 249B 2.71B 2.38B 2.19B 2.05B 3.85B 256B 3.93B 26.34B 10.19B 126B 10.18B 9.96B 438B
Net Debt 11.19B 9.81B 9.04B 8.46B 15.87B 1,055B 16.2B 109B 42.04B 521B 42B 41.08B 1,808B 8.44B 7.4B 6.82B 6.39B 11.97B 796B 12.22B 81.98B 31.72B 393B 31.69B 31B 1,364B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
26-06-26 US$33.21 -1.22% 4,703,604
26-06-25 US$33.62 -1.75% 7,448,003
26-06-24 US$34.22 +3.04% 7,249,291
26-06-23 US$33.21 +3.14% 5,567,372
26-06-22 US$32.20 +2.29% 6,111,093
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
33.21USD
Average target price
40.90USD
Spread / Average Target
+23.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TEVA Stock